Loading…
Associations among Alzheimer disease, depressive disorder, and risk of end-stage kidney disease in elderly people
Alzheimer disease (AD) and depressive disorder (DD) are prevalent among elderly end-stage kidney disease (ESKD) patients. However, whether preexisting mental health disorders increase the risk of ESKD is not well understood. The risk of incident ESKD in patients with or without underlying AD or DD w...
Saved in:
Published in: | Kidney research and clinical practice 2022, 41(6), , pp.753-763 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c436t-21dbf35ccb05997d301a1ebc08af54218ed9629f95c72b2b03b0d09a44e240013 |
---|---|
cites | |
container_end_page | 763 |
container_issue | 6 |
container_start_page | 753 |
container_title | Kidney research and clinical practice |
container_volume | 41 |
creator | Kang, Shin Chan Koh, Hee Byung Kim, Hyung Woo Joo, Young Su Han, Seung Hyeok Yoo, Tae-Hyun Kang, Shin-Wook Park, Jung Tak |
description | Alzheimer disease (AD) and depressive disorder (DD) are prevalent among elderly end-stage kidney disease (ESKD) patients. However, whether preexisting mental health disorders increase the risk of ESKD is not well understood. The risk of incident ESKD in patients with or without underlying AD or DD was evaluated in a nationwide cohort of elderly people in Republic of Korea.
This study used data from the National Health Insurance Service-Senior cohort in Republic of Korea. Among the 558,147 total subjects, 49,634 and 54,231 were diagnosed with AD (AD group) or DD (DD group), respectively, during the follow-up period. Propensity score matching was conducted to create non-AD and non-DD groups of subjects. AD and DD diagnoses were analyzed as time-varying exposures, and the study outcome was development of ESKD.
The incidence rates of ESKD were 0.36 and 1.17 per 1,000 person-years in the non-AD and AD groups, respectively. After adjustment for clinical variables and competing risks of death, the risk of incident ESKD was higher in the AD group than in the nonAD group (hazard ratio [HR], 1.67; 95% confidence interval [CI], 1.34-2.08). The incidence rates of ESKD in the non-DD and DD groups were 0.36 and 0.91 per 1,000 person-years, respectively. The risk of ESKD development was also higher in the DD group than the non-DD group (HR, 1.44; 95% CI, 1.19-1.76).
The risk of ESKD development was higher in subjects diagnosed with AD or DD, suggesting that central nervous system diseases can adversely affect kidney function in elderly people. |
doi_str_mv | 10.23876/j.krcp.21.311 |
format | article |
fullrecord | <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_10102087</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_46ac92828e504b95bfd7107ad5aed3ed</doaj_id><sourcerecordid>2732539692</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-21dbf35ccb05997d301a1ebc08af54218ed9629f95c72b2b03b0d09a44e240013</originalsourceid><addsrcrecordid>eNo9kctr3DAQxkVpSMI21xyLjqXEW2lk2dZxCX0sBAolOQs9xlutH3Ikb2H719fdTTIMzPDx-745DCG3nK1BNHX1Zb_ukpvWwNeC83fkGoDzQvGSvX_bBVyRm5z3bKmqKZWoLsmVqAQ0Sslr8rzJObpg5hDHTM0Qxx3d9H9_YxgwUR8ymox31OOUMOfwB_9rMXlMd9SMnqaQOxpbiqMv8mx2SLvgRzy-WmkYKfYL3h_phHHq8QO5aE2f8eZlrsjTt6-P9z-Kh5_ft_ebh8KVopoL4N62QjpnmVSq9oJxw9E61phWlsAb9KoC1SrparBgmbDMM2XKEqFkjIsV-XzOHVOrOxd0NOE0d1F3SW9-PW41Z5wBa-oF3p5hH81eTykMJh1PjpMQ006bNAfXoy4r4xQ00KBkpVXStr7mrDZeGvRi6RX5dM6aUnw-YJ71ELLDvjcjxkPWUAuQQlUKFvTjC3qwA_q3w6__Ef8AOo6S6Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2732539692</pqid></control><display><type>article</type><title>Associations among Alzheimer disease, depressive disorder, and risk of end-stage kidney disease in elderly people</title><source>PubMed Central(OpenAccess)</source><creator>Kang, Shin Chan ; Koh, Hee Byung ; Kim, Hyung Woo ; Joo, Young Su ; Han, Seung Hyeok ; Yoo, Tae-Hyun ; Kang, Shin-Wook ; Park, Jung Tak</creator><creatorcontrib>Kang, Shin Chan ; Koh, Hee Byung ; Kim, Hyung Woo ; Joo, Young Su ; Han, Seung Hyeok ; Yoo, Tae-Hyun ; Kang, Shin-Wook ; Park, Jung Tak</creatorcontrib><description>Alzheimer disease (AD) and depressive disorder (DD) are prevalent among elderly end-stage kidney disease (ESKD) patients. However, whether preexisting mental health disorders increase the risk of ESKD is not well understood. The risk of incident ESKD in patients with or without underlying AD or DD was evaluated in a nationwide cohort of elderly people in Republic of Korea.
This study used data from the National Health Insurance Service-Senior cohort in Republic of Korea. Among the 558,147 total subjects, 49,634 and 54,231 were diagnosed with AD (AD group) or DD (DD group), respectively, during the follow-up period. Propensity score matching was conducted to create non-AD and non-DD groups of subjects. AD and DD diagnoses were analyzed as time-varying exposures, and the study outcome was development of ESKD.
The incidence rates of ESKD were 0.36 and 1.17 per 1,000 person-years in the non-AD and AD groups, respectively. After adjustment for clinical variables and competing risks of death, the risk of incident ESKD was higher in the AD group than in the nonAD group (hazard ratio [HR], 1.67; 95% confidence interval [CI], 1.34-2.08). The incidence rates of ESKD in the non-DD and DD groups were 0.36 and 0.91 per 1,000 person-years, respectively. The risk of ESKD development was also higher in the DD group than the non-DD group (HR, 1.44; 95% CI, 1.19-1.76).
The risk of ESKD development was higher in subjects diagnosed with AD or DD, suggesting that central nervous system diseases can adversely affect kidney function in elderly people.</description><identifier>ISSN: 2211-9132</identifier><identifier>EISSN: 2211-9140</identifier><identifier>DOI: 10.23876/j.krcp.21.311</identifier><identifier>PMID: 36328995</identifier><language>eng</language><publisher>Korea (South): The Korean Society of Nephrology</publisher><subject>alzheimer disease ; depressive disorder ; elderly ; end-stage kidney disease ; 내과학</subject><ispartof>Kidney Research and Clinical Practice, 2022, 41(6), , pp.753-763</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-21dbf35ccb05997d301a1ebc08af54218ed9629f95c72b2b03b0d09a44e240013</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36328995$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002918423$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Kang, Shin Chan</creatorcontrib><creatorcontrib>Koh, Hee Byung</creatorcontrib><creatorcontrib>Kim, Hyung Woo</creatorcontrib><creatorcontrib>Joo, Young Su</creatorcontrib><creatorcontrib>Han, Seung Hyeok</creatorcontrib><creatorcontrib>Yoo, Tae-Hyun</creatorcontrib><creatorcontrib>Kang, Shin-Wook</creatorcontrib><creatorcontrib>Park, Jung Tak</creatorcontrib><title>Associations among Alzheimer disease, depressive disorder, and risk of end-stage kidney disease in elderly people</title><title>Kidney research and clinical practice</title><addtitle>Kidney Res Clin Pract</addtitle><description>Alzheimer disease (AD) and depressive disorder (DD) are prevalent among elderly end-stage kidney disease (ESKD) patients. However, whether preexisting mental health disorders increase the risk of ESKD is not well understood. The risk of incident ESKD in patients with or without underlying AD or DD was evaluated in a nationwide cohort of elderly people in Republic of Korea.
This study used data from the National Health Insurance Service-Senior cohort in Republic of Korea. Among the 558,147 total subjects, 49,634 and 54,231 were diagnosed with AD (AD group) or DD (DD group), respectively, during the follow-up period. Propensity score matching was conducted to create non-AD and non-DD groups of subjects. AD and DD diagnoses were analyzed as time-varying exposures, and the study outcome was development of ESKD.
The incidence rates of ESKD were 0.36 and 1.17 per 1,000 person-years in the non-AD and AD groups, respectively. After adjustment for clinical variables and competing risks of death, the risk of incident ESKD was higher in the AD group than in the nonAD group (hazard ratio [HR], 1.67; 95% confidence interval [CI], 1.34-2.08). The incidence rates of ESKD in the non-DD and DD groups were 0.36 and 0.91 per 1,000 person-years, respectively. The risk of ESKD development was also higher in the DD group than the non-DD group (HR, 1.44; 95% CI, 1.19-1.76).
The risk of ESKD development was higher in subjects diagnosed with AD or DD, suggesting that central nervous system diseases can adversely affect kidney function in elderly people.</description><subject>alzheimer disease</subject><subject>depressive disorder</subject><subject>elderly</subject><subject>end-stage kidney disease</subject><subject>내과학</subject><issn>2211-9132</issn><issn>2211-9140</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNo9kctr3DAQxkVpSMI21xyLjqXEW2lk2dZxCX0sBAolOQs9xlutH3Ikb2H719fdTTIMzPDx-745DCG3nK1BNHX1Zb_ukpvWwNeC83fkGoDzQvGSvX_bBVyRm5z3bKmqKZWoLsmVqAQ0Sslr8rzJObpg5hDHTM0Qxx3d9H9_YxgwUR8ymox31OOUMOfwB_9rMXlMd9SMnqaQOxpbiqMv8mx2SLvgRzy-WmkYKfYL3h_phHHq8QO5aE2f8eZlrsjTt6-P9z-Kh5_ft_ebh8KVopoL4N62QjpnmVSq9oJxw9E61phWlsAb9KoC1SrparBgmbDMM2XKEqFkjIsV-XzOHVOrOxd0NOE0d1F3SW9-PW41Z5wBa-oF3p5hH81eTykMJh1PjpMQ006bNAfXoy4r4xQ00KBkpVXStr7mrDZeGvRi6RX5dM6aUnw-YJ71ELLDvjcjxkPWUAuQQlUKFvTjC3qwA_q3w6__Ef8AOo6S6Q</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>Kang, Shin Chan</creator><creator>Koh, Hee Byung</creator><creator>Kim, Hyung Woo</creator><creator>Joo, Young Su</creator><creator>Han, Seung Hyeok</creator><creator>Yoo, Tae-Hyun</creator><creator>Kang, Shin-Wook</creator><creator>Park, Jung Tak</creator><general>The Korean Society of Nephrology</general><general>대한신장학회</general><scope>NPM</scope><scope>7X8</scope><scope>DOA</scope><scope>ACYCR</scope></search><sort><creationdate>20221101</creationdate><title>Associations among Alzheimer disease, depressive disorder, and risk of end-stage kidney disease in elderly people</title><author>Kang, Shin Chan ; Koh, Hee Byung ; Kim, Hyung Woo ; Joo, Young Su ; Han, Seung Hyeok ; Yoo, Tae-Hyun ; Kang, Shin-Wook ; Park, Jung Tak</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-21dbf35ccb05997d301a1ebc08af54218ed9629f95c72b2b03b0d09a44e240013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>alzheimer disease</topic><topic>depressive disorder</topic><topic>elderly</topic><topic>end-stage kidney disease</topic><topic>내과학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kang, Shin Chan</creatorcontrib><creatorcontrib>Koh, Hee Byung</creatorcontrib><creatorcontrib>Kim, Hyung Woo</creatorcontrib><creatorcontrib>Joo, Young Su</creatorcontrib><creatorcontrib>Han, Seung Hyeok</creatorcontrib><creatorcontrib>Yoo, Tae-Hyun</creatorcontrib><creatorcontrib>Kang, Shin-Wook</creatorcontrib><creatorcontrib>Park, Jung Tak</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Directory of Open Access Journals(OpenAccess)</collection><collection>Korean Citation Index</collection><jtitle>Kidney research and clinical practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kang, Shin Chan</au><au>Koh, Hee Byung</au><au>Kim, Hyung Woo</au><au>Joo, Young Su</au><au>Han, Seung Hyeok</au><au>Yoo, Tae-Hyun</au><au>Kang, Shin-Wook</au><au>Park, Jung Tak</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Associations among Alzheimer disease, depressive disorder, and risk of end-stage kidney disease in elderly people</atitle><jtitle>Kidney research and clinical practice</jtitle><addtitle>Kidney Res Clin Pract</addtitle><date>2022-11-01</date><risdate>2022</risdate><volume>41</volume><issue>6</issue><spage>753</spage><epage>763</epage><pages>753-763</pages><issn>2211-9132</issn><eissn>2211-9140</eissn><abstract>Alzheimer disease (AD) and depressive disorder (DD) are prevalent among elderly end-stage kidney disease (ESKD) patients. However, whether preexisting mental health disorders increase the risk of ESKD is not well understood. The risk of incident ESKD in patients with or without underlying AD or DD was evaluated in a nationwide cohort of elderly people in Republic of Korea.
This study used data from the National Health Insurance Service-Senior cohort in Republic of Korea. Among the 558,147 total subjects, 49,634 and 54,231 were diagnosed with AD (AD group) or DD (DD group), respectively, during the follow-up period. Propensity score matching was conducted to create non-AD and non-DD groups of subjects. AD and DD diagnoses were analyzed as time-varying exposures, and the study outcome was development of ESKD.
The incidence rates of ESKD were 0.36 and 1.17 per 1,000 person-years in the non-AD and AD groups, respectively. After adjustment for clinical variables and competing risks of death, the risk of incident ESKD was higher in the AD group than in the nonAD group (hazard ratio [HR], 1.67; 95% confidence interval [CI], 1.34-2.08). The incidence rates of ESKD in the non-DD and DD groups were 0.36 and 0.91 per 1,000 person-years, respectively. The risk of ESKD development was also higher in the DD group than the non-DD group (HR, 1.44; 95% CI, 1.19-1.76).
The risk of ESKD development was higher in subjects diagnosed with AD or DD, suggesting that central nervous system diseases can adversely affect kidney function in elderly people.</abstract><cop>Korea (South)</cop><pub>The Korean Society of Nephrology</pub><pmid>36328995</pmid><doi>10.23876/j.krcp.21.311</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2211-9132 |
ispartof | Kidney Research and Clinical Practice, 2022, 41(6), , pp.753-763 |
issn | 2211-9132 2211-9140 |
language | eng |
recordid | cdi_nrf_kci_oai_kci_go_kr_ARTI_10102087 |
source | PubMed Central(OpenAccess) |
subjects | alzheimer disease depressive disorder elderly end-stage kidney disease 내과학 |
title | Associations among Alzheimer disease, depressive disorder, and risk of end-stage kidney disease in elderly people |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A48%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Associations%20among%20Alzheimer%20disease,%20depressive%20disorder,%20and%20risk%20of%20end-stage%20kidney%20disease%20in%20elderly%20people&rft.jtitle=Kidney%20research%20and%20clinical%20practice&rft.au=Kang,%20Shin%20Chan&rft.date=2022-11-01&rft.volume=41&rft.issue=6&rft.spage=753&rft.epage=763&rft.pages=753-763&rft.issn=2211-9132&rft.eissn=2211-9140&rft_id=info:doi/10.23876/j.krcp.21.311&rft_dat=%3Cproquest_nrf_k%3E2732539692%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c436t-21dbf35ccb05997d301a1ebc08af54218ed9629f95c72b2b03b0d09a44e240013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2732539692&rft_id=info:pmid/36328995&rfr_iscdi=true |